ResMed Inc. (RMD) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 16:05 ET. Consensus EPS estimate is $2.69.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-06 | FY2026 Q2 | $2.89 | $2.95 | +2.1% | $1.46B |
| 2026-04-30 | FY2026 Q1 | $2.80 | $2.86 | +2.1% | $1.43B |
| 2026-01-29 | FY2025 Q4 | $2.74 | $2.81 | +2.6% | $1.42B |
| 2025-10-30 | FY2025 Q3 | $2.51 | $2.55 | +1.6% | $1.34B |
| 2025-07-31 | FY2025 Q2 | $2.55 | $2.55 | +0.0% | $1.35B |
| 2025-04-23 | FY2025 Q1 | $2.38 | $2.37 | -0.4% | $1.29B |
| 2025-01-30 | FY2024 Q4 | $2.32 | $2.43 | +4.7% | $1.28B |
| 2024-10-24 | FY2024 Q3 | $2.04 | $2.20 | +7.8% | $1.22B |
RMD has beaten consensus EPS in 7 of its last 8 reported quarters.
See RMD on the live calendar →